HCR 350 Module 4 Paper 4: Integrating Research Compliance Into the Corporate Compliance Program Example

Reviewed by Emmett Rockwell, MBA Arizona State University Updated October 2026

This HCR 350 Module 4 sample is Paper 4 in Introduction to Clinical Research, the clinical research course in ASU's Health Care Compliance and Regulations bachelor's. The last of four papers in ASU HCR 350 asks students to explain how research compliance can be integrated into an organization's corporate compliance program. The composite student writes for a health system that runs a busy clinical trials office alongside hospitals and clinics. She explains why research risks belong inside the main program, maps the seven building blocks of a sound compliance program onto research risks such as clinical trial billing, conflicts of interest, informed consent and data integrity and proposes a structure, reporting lines and an audit plan.

CourseHCR 350 Introduction to Clinical Research
ModuleModule 4
Paper typeCompliance program paper
LengthAbout 549 words, 4 pages
FormatAPA 7 student paper
SchoolArizona State University
ProgramBS in Health Care Compliance and Regulations
UpdatedOctober 2026

Free sample paper for HCR 350 Module 4

1

One Program, Not Two: Integrating Research Compliance Into a Health System's Compliance Program

Student Name

BS in Health Care Compliance and Regulations, Arizona State University

HCR 350: Introduction to Clinical Research

Instructor Name

Month Day, Year

What this page is doingThe title states the paper's recommendation in four words before naming the topic.
2

One Program, Not Two: Integrating Research Compliance Into a Health System's Compliance Program

Why Integration Matters

Many health systems built research compliance separately from corporate compliance: the institutional review board, sponsored programs office and research administration handle research rules, while the compliance office handles billing, privacy and fraud. But research risks do not stay in their lane. A trial patient's visit generates claims to Medicare; investigator payments raise conflict of interest questions; research data are protected health information. Separate programs miss problems that cross boundaries, and regulators expect organizations to manage risk as a whole.

The Seven Elements Applied to Research

Federal guidance issued in 2023 by the HHS Office of Inspector General groups the building blocks of a sound program into seven parts (Office of Inspector General, 2023), and each has a research counterpart:

ElementResearch application
Written policies and proceduresClinical trial billing, conflicts of interest, research data use and retention, consent
Compliance officer and committeeResearch compliance officer reports to the chief compliance officer; research leaders sit on the committee
Training and educationGood clinical practice, human subjects protection and research billing training for study staff
Effective lines of communicationHotline open to research staff; non-retaliation for reporting concerns about studies
Enforcing standardsConsequences for research misconduct and noncompliance applied consistently
Auditing and monitoringResearch billing audits, consent document reviews, investigator file reviews
Responding to problemsInvestigations, corrective action, refunds of improper claims, reports to agencies
What this page is doingMapping each of the seven elements onto a research risk shows exactly what integration means in practice rather than describing it in general terms.
3

Key Research Risks

Clinical trial billing. Services paid by a sponsor or promised free in the consent form must not also be billed to Medicare or the patient. Billing errors in trials are a frequent source of overpayments, and a coverage analysis for each study, linked to the billing system, prevents them.

Conflicts of interest. Investigators with financial interests in sponsors must disclose them, and the institution must manage them under federal rules for funded research.

Informed consent and human subjects protection. The IRB reviews and approves studies, but compliance auditing of consent documents provides a second line of defense. The ethical basis is well established: independent review and informed consent are among the core requirements for ethical clinical research (Emanuel et al., 2000).

Data integrity and misconduct. Fabricated or falsified data harm participants and the public; when FDA inspectors find significant problems, those findings rarely reach the published literature (Seife, 2015). Integrated monitoring can catch warning signs early.

Proposed Structure

The research compliance officer would report to the chief compliance officer, with a dotted line to the vice president for research. Research would be a standing item on the compliance committee's agenda, and research risks would be included in the annual enterprise risk assessment and audit plan. The IRB would remain independent in its ethical review while sharing findings on noncompliance with the compliance office.

Audit Plan for the First Year

1. Coverage analysis and claim review for ten active trials.

2. Consent document audit for twenty enrolled participants.

3. Conflict of interest disclosures for all investigators on industry-funded trials.

4. Review of research data access and privacy safeguards.

Conclusion

Integration does not mean the compliance office takes over research. It means research risks are managed with the same tools, attention and accountability as other risks, so that problems crossing billing, privacy and research rules are caught and corrected.

References

Emanuel, E. J., Wendler, D., & Grady, C. (2000). What makes clinical research ethical? JAMA, 283(20), 2701-2711. https://doi.org/10.1001/jama.283.20.2701

Office of Inspector General. (2023). General compliance program guidance. U.S. Department of Health and Human Services. https://oig.hhs.gov/compliance/general-compliance-program-guidance/

Seife, C. (2015). Research misconduct identified by the US Food and Drug Administration: Out of sight, out of mind. JAMA Internal Medicine, 175(4), 567-577. https://doi.org/10.1001/jamainternmed.2014.7774

What the HCR 350 Module 4 instructions ask for

Paper 4 closes HCR 350's series of four papers, worth 300 points together, and its topic is given in a single line: integrating research compliance into the corporate compliance program. Plan to explain what each kind of program covers, why bringing them together matters and how integration would work in practice. Federal compliance guidance and the course's required handbook provide the framework, and the seven-part structure of an effective compliance program is the usual organizing tool. Choose a type of organization, such as an academic medical center or a community hospital that runs trials, so that your recommendations can be concrete.

How the HCR 350 Module 4 example is put together

The sample opens by showing how research risks cross the boundary between research administration and corporate compliance. A table then applies each of the seven program building blocks to research, followed by a section on four specific risks: clinical trial billing, conflicts of interest, consent and human subjects protection and data integrity. The paper proposes reporting lines that preserve the IRB's independence and ends with a four-item audit plan for the first year. Its sources combine federal guidance with two peer-reviewed articles on research ethics and on FDA inspection findings. Tables keep the mapping compact.

Where the marks sit in the HCR 350 Module 4 rubric

Compliance program papers are marked on a Canvas rubric within the papers' combined 300 points. They usually earn credit for applying the seven-part program framework accurately, identifying concrete research risks, proposing practical integration steps, protecting the independence of ethical review, including an audit or monitoring plan and writing clearly with sources. They lose credit when integration stays abstract, when research risks are missing or misdescribed and when recommendations ignore how the organization is actually structured. Papers that also explain how research findings feed the organization's annual risk assessment, so that research is not treated as a separate world, tend to stand out, as do those that show how the board or its committee would receive reports on research compliance.

HCR 350 Module 4 help from the desk

Organize around the seven elements, since graders will be looking for them. Pick a handful of research risks and explain each in operational terms, such as how a coverage analysis prevents double billing. Show reporting lines clearly, perhaps with a simple chart. Add a short first-year audit plan to prove the program could work. Use the course handbook for research-specific detail. The desk can look over your structure before you begin drafting. Remember the IRB's special status: its ethical judgments must stay independent of institutional pressures, so describe how information is shared without placing the board under the compliance office. A short example of a problem that crosses boundaries, such as a billing error discovered during a consent audit, makes the case for integration vivid.

Write yours, or have the desk draft it

This paper is an original model document written by our desk, not a submitted student paper and not an official Arizona State University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.

More HCR 350 and BS in Health Care Compliance and Regulations sample papers

HCR 350 Module 4 questions, answered

Where can I find a free HCR 350 Module 4 sample paper?

This page carries a full HCR 350 Module 4 sample: a paper on integrating research compliance into a health system's compliance program.

What are the seven elements of a compliance program?

Policies, a designated officer with a committee, education, open reporting channels, consistent discipline, audits and monitoring and prompt corrective action.

What is clinical trial billing compliance?

Ensuring that services paid by a sponsor or promised free are not also billed to insurers or patients, usually through a coverage analysis.

Should the IRB report to the compliance office?

The IRB should remain independent in its ethical review while sharing noncompliance findings with the compliance program.

What does HCR 350 Paper 4 ask?

To discuss integrating research compliance into the corporate compliance program.